Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a randomized trial of MLN3897 in rheumatoid arthritis patients on methotrexate
2005-006165-14Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing MLN3897 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: ACR20 response at Day 84. Started May 2006; status: completed.
02
Drugs
MLN3897
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-006165-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006165-14.